Market Overview:
The global pilocarpine market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising prevalence of glaucoma and increasing demand for ophthalmic drugs. Based on type, the global pilocarpine market is segmented into injection and eye drop. The injection segment is expected to register a higher CAGR during the forecast period, owing to its advantages over other forms of administration. Based on application, the global pilocarpine market is segmented into eye clinic, hospital and others. The eye clinic segment dominates the overall market and is anticipated to maintain its dominance throughout the forecast period.
Product Definition:
Pilocarpine is a drug that is used to treat dry mouth and improve vision. It is a cholinergic drug that works by stimulating the release of acetylcholine. Pilocarpine can be used as eyedrops to improve vision in people with glaucoma and as a nasal spray to improve saliva production in people with dry mouth.
Injection:
Injection is a medication used for the treatment of muscle spasms and seizures. It works by changing the electrical activity in the brain. The drug Pilocarpine hydrochloride (Shi-Nao) is an injection used to treat multiple sclerosis, which is also known as “the great imitator” owing to its frequent symptoms: stiffness, pain, and spasticity (uncontrollable limb movement).
Eye Drop:
Pilocarpine is an eye drop used for the treatment of glaucoma and it's side effects. It works by widening the blood vessels to provide more blood flow, which helps in reducing pressure in the eyes. Pilocarpine is also used as an anti-inflammatory drug to reduce redness and itching caused due to inflammation.
Application Insights:
The others segment held the largest share of more than 50.0% in 2017. The segment includes clinics and hospitals as well as other application areas such as pharmacies and optometry offices. The demand for pilocarpine is increasing due to its benefits over other treatment options such as ice packs, heat packs, TENS machines, ultrasound devices and massage among others in various applications including post-surgical pain management, ocular pain relief (dry eye), corneal ulcers healing & scarring reduction (edema) among others.
Pilocarpine is used for the treatment of dry eyes due to its ability to reduce evaporation from the surface of the eye by about 60%.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D activities, rising healthcare expenditure, and growing demand for Pilocarpine hydrochloride in this region. In addition, high adoption of innovative products by end-users is also expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to untapped opportunities in this region coupled with high unmet clinical needs and rapidly improving healthcare infrastructure & reimbursement scenario as well as economic development & lifestyle changes amongst patients which are driving major regional markets such as India and China for ophthalmic disorders including diabetic retinopathy and glaucoma among others at a significant rate that requires immediate attention of regulatory bodies such as FDA/WHO etc.
Growth Factors:
- Increasing prevalence of glaucoma and other eye disorders: The increasing prevalence of glaucoma and other eye disorders is one of the key growth drivers for the Pilocarpine market. Glaucoma is a leading cause of blindness, and according to the World Health Organization (WHO), it affects around 57 million people worldwide. This number is expected to increase significantly in the next few years due to the aging population. The increasing incidence of other eye disorders such as age-related macular degeneration (AMD) and diabetic retinopathy is also contributing to the growth of the Pilocarpine market.
- Growing demand for ophthalmic drugs: The growing demand for ophthalmic drugs across all regions is another major driver for the Pilocarpine market. Ophthalmic drugs are used to treat various eye diseases such as glaucoma, AMD, diabetic retinopathy, etc., which are becoming increasingly common due to rising rates of diabetes and aging population. In addition, rising awareness about available treatment options has led more people towards seeking medical help for their vision problems, thereby driving demand for ophthalmic drugs including Pilocarpine products..
- Technological advancements in drug delivery systems: Another key factor driving growth in this market is technological advancements in drug delivery systems that are making it easier and more convenient for patients to take medications orally or through injections.. These advancements are helping manufacturers develop new dosage forms that offer better patient
Scope Of The Report
Report Attributes
Report Details
Report Title
Pilocarpine Market Research Report
By Type
Injection, Eye Drop
By Application
Eye Clinic, Hospital, Others
By Companies
AUROBINDO PHARMA LTD, Kissei, NOVARTIS, AKORN INC, SOMERSET THERAPS LLC, IMPAX LABS, Santen Oy, King York, Sandoz, Novartis AG, Rebel Distributors Corp.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Pilocarpine Market Report Segments:
The global Pilocarpine market is segmented on the basis of:
Types
Injection, Eye Drop
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Eye Clinic, Hospital, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AUROBINDO PHARMA LTD
- Kissei
- NOVARTIS
- AKORN INC
- SOMERSET THERAPS LLC
- IMPAX LABS
- Santen Oy
- King York
- Sandoz
- Novartis AG
- Rebel Distributors Corp.
Highlights of The Pilocarpine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection
- Eye Drop
- By Application:
- Eye Clinic
- Hospital
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pilocarpine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pilocarpine is a medication used to treat glaucoma. It works by decreasing the amount of fluid in the eye.
Some of the major players in the pilocarpine market are AUROBINDO PHARMA LTD, Kissei, NOVARTIS, AKORN INC, SOMERSET THERAPS LLC, IMPAX LABS, Santen Oy, King York, Sandoz, Novartis AG, Rebel Distributors Corp..
The pilocarpine market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pilocarpine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pilocarpine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pilocarpine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pilocarpine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pilocarpine Market Size & Forecast, 2018-2028
4.5.1 Pilocarpine Market Size and Y-o-Y Growth
4.5.2 Pilocarpine Market Absolute $ Opportunity
Chapter 5 Global Pilocarpine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pilocarpine Market Size Forecast by Type
5.2.1 Injection
5.2.2 Eye Drop
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pilocarpine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pilocarpine Market Size Forecast by Applications
6.2.1 Eye Clinic
6.2.2 Hospital
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pilocarpine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pilocarpine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pilocarpine Analysis and Forecast
9.1 Introduction
9.2 North America Pilocarpine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pilocarpine Market Size Forecast by Type
9.6.1 Injection
9.6.2 Eye Drop
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pilocarpine Market Size Forecast by Applications
9.10.1 Eye Clinic
9.10.2 Hospital
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pilocarpine Analysis and Forecast
10.1 Introduction
10.2 Europe Pilocarpine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pilocarpine Market Size Forecast by Type
10.6.1 Injection
10.6.2 Eye Drop
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pilocarpine Market Size Forecast by Applications
10.10.1 Eye Clinic
10.10.2 Hospital
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pilocarpine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pilocarpine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pilocarpine Market Size Forecast by Type
11.6.1 Injection
11.6.2 Eye Drop
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pilocarpine Market Size Forecast by Applications
11.10.1 Eye Clinic
11.10.2 Hospital
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pilocarpine Analysis and Forecast
12.1 Introduction
12.2 Latin America Pilocarpine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pilocarpine Market Size Forecast by Type
12.6.1 Injection
12.6.2 Eye Drop
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pilocarpine Market Size Forecast by Applications
12.10.1 Eye Clinic
12.10.2 Hospital
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pilocarpine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pilocarpine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pilocarpine Market Size Forecast by Type
13.6.1 Injection
13.6.2 Eye Drop
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pilocarpine Market Size Forecast by Applications
13.10.1 Eye Clinic
13.10.2 Hospital
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pilocarpine Market: Competitive Dashboard
14.2 Global Pilocarpine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AUROBINDO PHARMA LTD
14.3.2 Kissei
14.3.3 NOVARTIS
14.3.4 AKORN INC
14.3.5 SOMERSET THERAPS LLC
14.3.6 IMPAX LABS
14.3.7 Santen Oy
14.3.8 King York
14.3.9 Sandoz
14.3.10 Novartis AG
14.3.11 Rebel Distributors Corp.
